These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 18204475

  • 21. Cross regulation between cGMP-dependent protein kinase and Akt in vasodilatation of porcine pulmonary artery.
    Liu J, Liu H, Li Y, Xu X, Chen Z, Liu L, Yu X, Gao Y, Dou D.
    J Cardiovasc Pharmacol; 2014 Nov; 64(5):452-9. PubMed ID: 24977346
    [Abstract] [Full Text] [Related]

  • 22. Individual cerebellar Purkinje cells express different cGMP phosphodiesterases (PDEs): in vivo phosphorylation of cGMP-specific PDE (PDE5) as an indicator of cGMP-dependent protein kinase (PKG) activation.
    Shimizu-Albergine M, Rybalkin SD, Rybalkina IG, Feil R, Wolfsgruber W, Hofmann F, Beavo JA.
    J Neurosci; 2003 Jul 23; 23(16):6452-9. PubMed ID: 12878685
    [Abstract] [Full Text] [Related]

  • 23. The phosphodiesterase inhibitory selectivity and the in vitro and in vivo potency of the new PDE5 inhibitor vardenafil.
    Saenz de Tejada I, Angulo J, Cuevas P, Fernández A, Moncada I, Allona A, Lledó E, Körschen HG, Niewöhner U, Haning H, Pages E, Bischoff E.
    Int J Impot Res; 2001 Oct 23; 13(5):282-90. PubMed ID: 11890515
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Inhibition of cGMP phosphodiesterase 5 suppresses matrix metalloproteinase-2 production in pulmonary artery smooth muscles cells.
    Sun XZ, Li ZF, Liu Y, Fang P, Li MX.
    Clin Exp Pharmacol Physiol; 2010 Mar 23; 37(3):362-7. PubMed ID: 19793106
    [Abstract] [Full Text] [Related]

  • 26. Inhibition of Galphaq-dependent PLC-beta1 activity by PKG and PKA is mediated by phosphorylation of RGS4 and GRK2.
    Huang J, Zhou H, Mahavadi S, Sriwai W, Murthy KS.
    Am J Physiol Cell Physiol; 2007 Jan 23; 292(1):C200-8. PubMed ID: 16885398
    [Abstract] [Full Text] [Related]

  • 27. ANF elicits phosphorylation of the cGMP phosphodiesterase in vascular smooth muscle cells.
    Wyatt TA, Naftilan AJ, Francis SH, Corbin JD.
    Am J Physiol; 1998 Feb 23; 274(2):H448-55. PubMed ID: 9486247
    [Abstract] [Full Text] [Related]

  • 28. Compartmentation and compartment-specific regulation of PDE5 by protein kinase G allows selective cGMP-mediated regulation of platelet functions.
    Wilson LS, Elbatarny HS, Crawley SW, Bennett BM, Maurice DH.
    Proc Natl Acad Sci U S A; 2008 Sep 09; 105(36):13650-5. PubMed ID: 18757735
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. cGMP-dependent protein kinase mediates stimulation of L-type calcium current by cGMP in rabbit atrial cells.
    Wang Y, Wagner MB, Joyner RW, Kumar R.
    Cardiovasc Res; 2000 Nov 09; 48(2):310-22. PubMed ID: 11054477
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Nitric oxide/cGMP/PKG signaling pathway activated by M1-type muscarinic acetylcholine receptor cascade inhibits Na+-activated K+ currents in Kenyon cells.
    Hasebe M, Yoshino M.
    J Neurophysiol; 2016 Jun 01; 115(6):3174-85. PubMed ID: 26984419
    [Abstract] [Full Text] [Related]

  • 33. Effects of Chaga Medicinal Mushroom Inonotus obliquus (Agaricomycetes) Extracts on NOS-cGMP-PDE5 Pathway in Rat Penile Smooth Muscle Cells.
    Liao H, Jia D, Zhao X, Zheng D, Li Y, Li R.
    Int J Med Mushrooms; 2020 Jun 01; 22(10):979-990. PubMed ID: 33426827
    [Abstract] [Full Text] [Related]

  • 34. Direct activation of PDE5 by cGMP: long-term effects within NO/cGMP signaling.
    Mullershausen F, Friebe A, Feil R, Thompson WJ, Hofmann F, Koesling D.
    J Cell Biol; 2003 Mar 03; 160(5):719-27. PubMed ID: 12604588
    [Abstract] [Full Text] [Related]

  • 35. Luteinizing Hormone Causes Phosphorylation and Activation of the cGMP Phosphodiesterase PDE5 in Rat Ovarian Follicles, Contributing, Together with PDE1 Activity, to the Resumption of Meiosis.
    Egbert JR, Uliasz TF, Shuhaibar LC, Geerts A, Wunder F, Kleiman RJ, Humphrey JM, Lampe PD, Artemyev NO, Rybalkin SD, Beavo JA, Movsesian MA, Jaffe LA.
    Biol Reprod; 2016 May 03; 94(5):110. PubMed ID: 27009040
    [Abstract] [Full Text] [Related]

  • 36. Melatonin inhibits nitric oxide signaling by increasing PDE5 phosphorylation in coronary arteries.
    Shukla P, Sun C, O'Rourke ST.
    Am J Physiol Heart Circ Physiol; 2012 Dec 15; 303(12):H1418-25. PubMed ID: 23086989
    [Abstract] [Full Text] [Related]

  • 37. Allosteric sites of phosphodiesterase-5 sequester cyclic GMP.
    Kotera J, Francis SH, Grimes KA, Rouse A, Blount MA, Corbin JD.
    Front Biosci; 2004 Jan 01; 9():378-86. PubMed ID: 14766375
    [Abstract] [Full Text] [Related]

  • 38. Increased expression of the cGMP-inhibited cAMP-specific (PDE3) and cGMP binding cGMP-specific (PDE5) phosphodiesterases in models of pulmonary hypertension.
    Murray F, MacLean MR, Pyne NJ.
    Br J Pharmacol; 2002 Dec 01; 137(8):1187-94. PubMed ID: 12466227
    [Abstract] [Full Text] [Related]

  • 39. cGMP-dependent protein kinase protects cGMP from hydrolysis by phosphodiesterase-5.
    Kotera J, Grimes KA, Corbin JD, Francis SH.
    Biochem J; 2003 Jun 01; 372(Pt 2):419-26. PubMed ID: 12617722
    [Abstract] [Full Text] [Related]

  • 40. PDE5 is converted to an activated state upon cGMP binding to the GAF A domain.
    Rybalkin SD, Rybalkina IG, Shimizu-Albergine M, Tang XB, Beavo JA.
    EMBO J; 2003 Feb 03; 22(3):469-78. PubMed ID: 12554648
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.